AN2 Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
ANTX
CUSIP
037326105
Type
Equity
Class
COM
Num filings
52
Total reported value, excl. options
$74.8 M
Manager Report Date Value ($000) Shares Option Type